Integrated Diagnostics Holdings plc (IDHCL.XC)
Cboe UK · USD · Healthcare · Diagnostics & Research
$0.505 (+5.21%) as of
Key statistics
- Market cap
- 316.52M
- P/E (TTM)
- 10.10
- EPS (TTM)
- 0.0500
- Dividend yield
- 1.77%
- 52-week range
- 0.4800 – 0.8200
- Beta
- 0.41
- Profit margin
- 16.71%
- Volume
- 1.07k
About Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Saint Helier, Jersey
- Employees
- 7,137
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.